Please use this identifier to cite or link to this item:
|Title:||Good distribution practice guidelines|
Azzopardi, Lilian M.
|Keywords:||Pharmaceutical industry -- Standards -- European Union countries|
Pharmaceutical industry -- European Union countries -- Quality control
Pharmaceutical policy -- Malta -- Evaluation
|Publisher:||University of Malta. Department of Pharmacy|
|Citation:||Giudice, L., Wirth, F., Serracino-Inglott, A., & Azzopardi, L. M. (2016, April). Good distribution practice guidelines. Poster session presented at the 10th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Glasgow, UK.|
|Abstract:||A poster presentation regarding good distribution practice guidelines. Introduction: An update of the European Union (EU) Guidelines on ‘Good Distribution Practice (GDP) of medicinal products for human use’ (2013/C 343/01) was published by the European Commission on November 5, 2013. Drug regulation serves to promote and secure public health and well being. Non-adherence to GDP guidelines may lead to an increase in unwanted adverse effects caused by medicines being of poor quality.|
|Appears in Collections:||Scholarly Works - FacM&SPha|
Files in This Item:
|Good_distribution_practice_guidelines_2016.pdf||795 kB||Adobe PDF||View/Open|
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.